Nuclear Radiology: Page 33

Australian agency orders review of Mo-99 procedures

By Brian Casey

An Australian government agency has ordered a review of radiation safety procedures at another federal agency in charge of running the nuclear reactor that was forced to stop shipments of the radioisotope molybdenum-99 (Mo-99) last month. The halt has spurred an ongoing shortage of important radiopharmaceuticals in the country.

July 26, 2018

FLT-PET points toward survival for glioblastoma patients

By Wayne Forrest

PET scans with the radiotracer F-18 fluorothymidine (FLT) can help determine which glioblastoma patients have the best chance for longer survival, according to a study published online on July 21 in the European Journal of Nuclear Medicine and Molecular Imaging.

July 24, 2018

Europe updates FDG-PET guidelines for neurodegenerative disorders

By AuntMinnieEurope.com staff writers

A joint task force of the European Association of Nuclear Medicine (EANM) and the European Academy of Neurology (EAN) has released new guidelines concerning the use of FDG-PET for neurodegenerative disorders.

July 17, 2018

NTP execs return to work after inquiry

By AuntMinnieEurope.com staff writers

Three senior executives at South African radioisotope firm NTP Radioisotopes are back on the job after the completion of a government inquiry into a breach of safety regulations at the firm's radiochemicals complex last year.

July 11, 2018

PET finds why some dementia patients live longer

By Wayne Forrest

A follow-up study by German researchers has pinpointed the presence of frontotemporal lobar degeneration as the determining factor to explain why Alzheimer's patients with amyloid-positive PET scans can outlive patients with negative amyloid results.

July 9, 2018

Australian reactor woes worry nuclear medicine

By Brian Casey

The shutdown of shipments from a nuclear reactor in Australia that is a key part of the global supply network for the radioisotope molybdenum-99 is causing consternation in the nuclear medicine community, particularly in the Asia-Pacific region.

July 6, 2018

ITG, Bruce Power team up on lutetium-177 production

By AuntMinnieEurope.com staff writers

German firm Isotope Technologies Garching (ITG) and nuclear reactor operator Bruce Power have signed a memorandum of understanding for the joint production of the radioisotope lutetium-177.

July 5, 2018

Cardiac hybrid imaging predicts adverse cardiac events

By Abraham Kim

A cardiac hybrid imaging technique that fuses SPECT myocardial perfusion imaging with coronary CT angiography scans can help predict major adverse cardiac events in patients suspected of having coronary artery disease, according to a study published online on 3 July in Radiology.

July 5, 2018

Medsquare takes French radiation dose contract

By AuntMinnieEurope.com staff writers

Radiation dose management firm Medsquare was awarded a contract from the Institut Curie for Medsquare's Radiation Dose Monitor software.

July 1, 2018

Brexit concerns remain in the U.K.

By AuntMinnieEurope.com staff writers

Healthcare providers in the U.K. continue to voice their concerns over the coming consummation of Brexit in March 2019, when the nation is set to leave the European Union.

July 1, 2018

Start-up to develop arthritis molecular imaging agent

By AuntMinnieEurope.com staff writers

U.K. life sciences developer Serac Life Sciences has established a new company, Serac Healthcare, to develop a molecular imaging agent that will help rheumatologists manage treatment for their arthritis patients.

June 27, 2018

Are amyloid PET scans ready for the clinical setting?

By Wayne Forrest

The use of PET scans to confirm the presence of dementia-inducing amyloid plaque in the brain may be ready for routine clinical use, based on a prospective study published online June 11 in JAMA Neurology. Researchers found that both positive and negative results influenced the diagnosis and treatment of patients with and without dementia.

June 20, 2018

Previous Page

Page 33 of 90

Next Page